Cite
HARVARD Citation
Durmo, R. et al. (2022). Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study. Hematological oncology. 40 (4), pp. 645-657. [Online].